15.06.09 07:15 Age: 271 days
Ipsogen announces the success of a €2.5 million reserved capital increase
Category: Investors
Marseille, June 15th 2009 - IPSOGEN (Alternext - FR0010626028 - ALIPS), a cancer ‘profiler’ that develops, manufactures and markets molecular diagnostic tests for leukemia and breast cancer, today announces that it has successfully carried out a €2.5 million capital increase.
More
